Non-cancer Pain and Cognitive Impairment: A Disabling Relationship
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01264965
To compare the efficacy of long-acting oxycodone to extended-release acetaminophen in older persons with no and mild to moderate cognitive impairment and persistent moderate or higher intensity non-cancer lower extremity arthritis pain; and Describe the association of change in non-cancer pain self-report with an older adults functional status (BPI and WOMAC and brief physical performance measure) and to determine if cognitive status modifies this relationship.
Condition or disease
Drug: long acting oxycodoneDrug: extra strength acetaminophen
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
65 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
age over 65
Pain at least 3 months duration
Pain greater in lower extremity than other anatomical site with ambulation
Pain self-report of moderate intensity of higher on an average day
Physician states participants have decision-making capacity to enroll into the trial
Participants with cognitive impairment have a reliable caregiver
Inadequate pain relief from NSAIDS and/or acetaminophen in the past
Current cancer requiring chemotherapy
History of addiction to opioids or other controlled substance
Consumes more than 2 alcoholic drinks a day
Severe balance disturbance
Intra-articular steroid injection in the past 6 weeks